查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1167449

生物模拟的全球市场(2022年)- 各零件，各用途，各终端用户，各地区，各国分析:市场洞察与预测(2018年～2028年)

Global Biosimulation Market (2022 Edition) - Analysis By Component (Software, Service), Application (Drug Discovery, Pre-Clinical, Clinical), End-User, By Region, By Country: Market Insights and Forecast (2018-2028)
出版日期: | 出版商: Azoth Analytics | 英文 270 Pages | 订单完成后即时交付

价格

全球生物模拟的市场规模，2021年是30亿1,150万美金。

本报告提供全球生物模拟市场相关调查，市场概要，以及各零件，各用途，各终端用户，各地区的趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 市场动态

  • 促进因素
  • 阻碍因素
  • 机会
  • 趋势
  • 市场动态的影响评估

第5章 价值链分析

  • 研究开发
  • 主要的开发商与供应商
  • 製药公司前十大企业
  • 最终用途产业

第6章 COVID-19影响评估

第7章 波特的五力分析

第8章 宏观经济指标预测

第9章 平均销售价格分析

第10章 竞争上的定位

  • 公司零组件的地位
  • 市场上地位矩阵
  • 市场占有率分析
    • Certara, Inc.
    • Simulations Plus, Inc.
    • Schr^dinger, Inc.
    • Dassault SystEmes
    • Physiomics plc
    • Thermo Fisher Scientific
    • Instem plc
    • Advanced Chemistry Development, Inc.
    • Chemical Computing Group
    • Optibrium

第11章 全球生物模拟市场趋势与预测分析，2018年～2028年，100万美元，年复合成长率

  • 宏观经济要素影响指数
  • 世界生物模拟市场:仪表板
  • 全球生物模拟市场规模，2018年～2021年(100万美元)
  • 全球生物模拟市场规模，2022年～2028年(100万美元)
  • 全球生物模拟市场:概要

第12章 全球生物模拟市场趋势与预测分析，2018年～2028年，各零件

  • 全球生物模拟市场趋势与预测分析:概述，各零件
  • 软体
  • 服务

第13章 全球生物模拟市场趋势与预测分析，2018年～2028年，各用途

  • 全球生物模拟市场趋势与预测分析:概述，各用途
  • 药物研发
  • 前临床
  • 临床

第14章 全球生物模拟市场趋势与预测分析，2018年～2028年，各终端用户

  • 全球生物模拟市场趋势与预测分析:概述，各终端用户
  • 学术，政府研究机关
  • 製药公司，生物科技企业
  • CRO
  • 法规当局

第15章 全球生物模拟市场趋势与预测分析，2018年～2028年，各地区

第16章 南北美洲的生物模拟市场趋势与预测分析，2018年～2028年，100万美元，年复合成长率

第17章 欧洲的生物模拟市场趋势与预测分析，2018年～2028年，100万美元，年复合成长率

第18章 亚太地区的生物模拟市场趋势与预测分析，2018年～2028年，100万美元，年复合成长率

第19章 中东、非洲的生物模拟市场趋势与预测分析，2018年～2028年，100万美元，年复合成长率

Executive Summary

According to a research report published by Azoth Analytics in November 2022, the Global Biosimulation Market was valued at USD 3011.50 Million in the year 2021. Biosimulation helps to increase the probability of success in human clinical trials, the most expensive part of drug development. Biosimulation helps to optimize dosing for different populations for enhanced safety and efficacy. New drugs can cause significant increases in retail spending because they are more expensive, in high demand, or both. Currently, In-Silico methods are outpacing various stages of drug discovery, particularly in biomedicine sciences.

Biosimulation drug discovery offers numerous opportunities for error elimination through computer simulation, which can improve drug performance and accuracy. In the forthcoming years, there will be more potential for the Biosimulation market to flourish due to the expanding applications and rising use of personalized medicine and biosimulation solutions for the development of paediatric drugs. Companies around the world use key strategies such as Component launches, business expansions, mergers and acquisitions, patents and approvals, agreements and collaborations.

The key software methods for developing a drug are structure-based drug design, molecular modelling, structure-based virtual screening, ligand interaction, and molecular dynamics. New technologies such as virtual reality and artificial intelligence (AI) are expanding the opportunities for drug discovery. Americas has the lucrative growth in the Biosimulation industry and the United States remains the country with the earliest launches accounting for 72 NASs launched in 2021.

Scope of the Report

  • The report presents the analysis of the Biosimulation market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028.
  • The report analyses the Biosimulation Market by Value (USD Million).
  • The report analyses the Biosimulation Market by Component (Software, Service)
  • The report analyses the Biosimulation Market by Application (Drug Discovery, Pre-Clinical, Clinical)
  • The report analyses the Biosimulation Market by End-User (Academic & Government Research Institutes, Pharmaceutical & Biotech Companies, Contract Research Organization, Regulatory Authorities)
  • The Global Biosimulation Market has been analysed by countries (United States, Canada, Mexico, Germany, United Kingdom, France, Italy, China, Japan, India)
  • The attractiveness of the market has been presented by region, by Component, Application and End-User.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include - Certara, Inc., Simulations Plus, Inc., Schrodinger, Inc., Dassault Systemes, Physiomics plc, Thermo Fisher Scientific, Instem plc, Advanced Chemistry Development, Inc., Chemical Computing Group, Optibrium

Key Target Audience

  • Pharmaceutical and Healthcare Companies
  • Pharmaceutical Research and Development Companies
  • Consulting and Advisory Firms
  • Government and Policy Makers
  • Regulatory Authorities

Table of Contents

1. Introduction

  • 1.1 Biosimulation Overview
  • 1.2 Scope of Research

2. Executive Summary

  • 2.1 Market Dashboard
  • 2.2 Regional Insights
  • 2.3 Market Ecosystem Factors

3. Research Methodology

  • 3.1 Data Collection Process
  • 3.2 Market Trajectory Estimation
  • 3.3 Market Size Calculation

4. Market Dynamics

  • 4.1 Drivers
  • 4.2 Restraints
  • 4.3 Opportunities
  • 4.4 Trends
  • 4.5 Impact assessment of Market Dynamics

5. Value Chain Analysis

  • 5.1 Research and Development
  • 5.2 Leading Developers and Providers
  • 5.3 Top Ten Pharma Companies
  • 5.4 End Use Industry

6. Covid-19 Impact Assessment

  • 6.1 Assessment of Degree of Impact of Covid-19 on the Biosimulation Market
  • 6.2 Region-Wise Quarterly Covid Impact Analysis

7. Porter's Five Forces Analysis

8. Macro Economic Indicator Outlook

  • 8.1 Pharmaceutical Industry Growth
  • 8.2 Global Healthcare Expenditure
  • 8.3 Global Biopharma R&D Spending
  • 8.4 Medicines in Development
  • 8.5 Global Software Industry

9. Average Selling Price Analysis

  • 9.1 Average Selling Price, By Region
  • 9.2 Average Selling Price, By Component

10. Competitive Positioning

  • 10.1 Companies Component Positioning
  • 10.2 Market Position Matrix
  • 10.3 Market Share Analysis
    • 10.3.1 Certara, Inc.
    • 10.3.2 Simulations Plus, Inc.
    • 10.3.3 Schr^dinger, Inc.
    • 10.3.4 Dassault SystEmes
    • 10.3.5 Physiomics plc
    • 10.3.6 Thermo Fisher Scientific
    • 10.3.7 Instem plc
    • 10.3.8 Advanced Chemistry Development, Inc.
    • 10.3.9 Chemical Computing Group
    • 10.3.10 Optibrium

11. Global Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

  • 11.1 Macro Economic Factor Impact Index
  • 11.2 Global Biosimulation Market: Dashboard
  • 11.3 Global Biosimulation Market Size, By Value, 2018-2021 (USD Million)
  • 11.4 Global Biosimulation Market Size, By Value, 2022-2028 (USD Million)
  • 11.5 Global Biosimulation Market: Summary

12. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By Component

  • 12.1 Global Biosimulation Market Trend And Forecast Analysis, By Component: Snapshot
  • 12.2 Software
  • 12.3 Service

13. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By Application

  • 13.1 Global Biosimulation Market Trend And Forecast Analysis, By Application: Snapshot
  • 13.2 Drug Discovery
  • 13.3 Pre-Clinical
  • 13.4 Clinical

14. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By End-User

  • 14.1 Global Biosimulation Market Trend And Forecast Analysis, By End-User: Snapshot
  • 14.2 Academic & Government Research Institutes
  • 14.3 Pharmaceutical & Biotech Companies
  • 14.4 Contract Research Organization
  • 14.5 Regulatory Authorities

15. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By Region

  • 15.1 Regional Coverage of the Study

16. Americas Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

  • 16.1 Macro Economic Factor Impact Index
  • 16.2 Impact analysis of market dynamics on Biosimulation Market
  • 16.3 Americas Biosimulation Market: Dashboard
  • 16.4 Americas Biosimulation Market Size, By Value, 2018-2021(USD Million)
  • 16.5 Americas Biosimulation Market Size, By Value, 2022-2028 (USD Million)
  • 16.6 Americas Biosimulation Market Trend And Forecast Analysis: Segmentation
    • 16.6.1 By Component
    • 16.6.2 By Application
    • 16.6.3 By End-User
    • 16.6.4 By Country
      • 16.6.4.1 United States
      • 16.6.4.2 Canada
      • 16.6.4.3 Mexico
      • 16.6.4.4 Rest of Americas

17. Europe Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

  • 17.1 Macro Economic Factor Impact Index
  • 17.2 Impact analysis of market dynamics on Biosimulation Market
  • 17.3 Europe Biosimulation Market: Dashboard
  • 17.4 Europe Biosimulation Market Size, By Value, 2018-2021(USD Million)
  • 17.5 Europe Biosimulation Market Size, By Value, 2022-2028 (USD Million)
  • 17.6 Europe Biosimulation Market Trend And Forecast Analysis: Segmentation
    • 17.6.1 By Component
    • 17.6.2 By Application
    • 17.6.3 By End-User
    • 17.6.4 By Country
      • 17.6.4.1 Germany
      • 17.6.4.2 United Kingdom
      • 17.6.4.3 France
      • 17.6.4.4 Italy
      • 17.6.4.5 Rest of Europe

18. Asia Pacific Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

  • 18.1 Macro Economic Factor Impact Index
  • 18.2 Impact analysis of market dynamics on Biosimulation Market
  • 18.3 Asia Pacific Biosimulation Market: Dashboard
  • 18.4 Asia Pacific Biosimulation Market Size, By Value, 2018-2021(USD Million)
  • 18.5 Asia Pacific Biosimulation Market Size, By Value, 2022-2028 (USD Million)
  • 18.6 Asia Pacific Biosimulation Market Trend And Forecast Analysis: Segmentation
    • 18.6.1 By Component
    • 18.6.2 By Application
    • 18.6.3 By End-User
    • 18.6.4 By Country
      • 18.6.4.1 China
      • 18.6.4.2 Japan
      • 18.6.4.3 India
      • 18.6.4.4 Rest of APAC

19. Middle East & Africa Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

  • 19.1 Impact analysis of market dynamics on Biosimulation Market
  • 19.2 Middle East & Africa Biosimulation Market: Snapshot
  • 19.3 Middle East & Africa Biosimulation Market Size, By Value, 2018-2021(USD Million)
  • 19.4 Middle East & Africa Biosimulation Market Size, By Value, 2022-2028 (USD Million)
  • 19.6 Middle East & Africa Biosimulation Market Trend And Forecast Analysis: Segmentation
    • 19.6.1 By Component
    • 19.6.2 By Application
    • 19.6.3 By End-User

List of Figures

List of Figures

  • Figure 1: Biosimulation Market for next 7 years (in USD Millions)
  • Figure 2: Biosimulation Market Size, By Component, 2018 & 2028 (USD Million)
  • Figure 3: Biosimulation Market Size, Leading Application, 2021 (%)
  • Figure 4: Average Selling Price, By Region, 2021 (USD/One Time License)
  • Figure 5: Average Selling Price, By Component, 2021 (USD/One Time License)
  • Figure 6: Market Share of Prominent Companies of Biosimulation, 2021 (%)
  • Figure 7: Certara, Inc. Revenues, 2019-2021 (USD Million)
  • Figure 8: Certara, Inc. Revenue By Business Segment, 2021 (%)
  • Figure 9: Certara, Inc. Revenue By Geographic Segment, 2021 (%)
  • Figure 10: Simulations Plus, Inc. Revenues, 2019-2021 (USD Million)
  • Figure 11: Simulations Plus, Inc., Revenue By Business Segment, 2021 (%)
  • Figure 12: Simulations Plus, Inc., Revenue By Geographic Segment, 2021 (%)
  • Figure 13: Schr^dinger, Inc. Revenues, 2019-2021 (USD Million)
  • Figure 14: Schr^dinger, Inc. Revenue By Business Segment, 2021 (%)
  • Figure 15: Schr^dinger, Inc. Revenue By Geographic Segment, 2021 (%)
  • Figure 16: Dassault SystEmes Revenues, 2019-2021 (USD Million)
  • Figure 17: Dassault SystEmes Revenue By Business Segment, 2021 (%)
  • Figure 18: Dassault SystEmes Revenue By Geographic Segment, 2021 (%)
  • Figure 19: Physiomics plc Revenues, 2019-2021 (USD Million)
  • Figure 20: Thermo Fisher Scientific Revenues, 2019-2021 (USD Million)
  • Figure 21: Thermo Fisher Revenue By Business Segment, 2021 (%)
  • Figure 22: Thermo Fisher Revenue By Geographic Segment, 2021 (%)
  • Figure 23: Instem plc Revenues, 2019-2021 (USD Million)
  • Figure 24: Instem plc Revenue By Business Segment, 2021 (%)
  • Figure 25: Instem plc Revenue By Geographic Segment, 2021 (%)
  • Figure 26: At a CAGR of 16.28% during 2023-2028, the global market value is expected to reach USD 8645.43 Million in 2028
  • Figure 27: Sales of Software is expected to contribute a share of 63.84% in 2021
  • Figure 28: Basis Point Analysis of Global Biosimulation Market, By Region (2022, 2028)
  • Figure 29: Market Opportunity Analysis of Global Biosimulation Market, By Region (2023-2028)
  • Figure 30: Global Biosimulation Market Size, By Value, 2018-2021(USD Million)
  • Figure 31: Global Biosimulation Market Size, By Value, 2022-2028 (USD Million)
  • Figure 32: Global Biosimulation Market Share, By Component, 2021 (%)
  • Figure 33: Global Biosimulation Market CAGR, By Component, By Value, 2018-2021, 2023-2028 (%)
  • Figure 34: Basis Point Analysis of Global Biosimulation Market, By Component (2022, 2028)
  • Figure 35: Market Opportunity Analysis of Global Biosimulation Market, By Component (2023-2028)
  • Figure 36: Global Biosimulation Market Size, By Component, Software, By Value, 2018-2021 (USD Million)
  • Figure 37: Global Biosimulation Market Size, By Component, Software, By Value, 2022-2028 (USD Million)
  • Figure 38: Global Biosimulation Market Absolute Opportunity, By Component, Software, 2018-2028 (USD Million)
  • Figure 39: Global Biosimulation Market Size, By Component, Service, By Value, 2018-2021 (USD Million)
  • Figure 40: Global Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
  • Figure 41: Global Biosimulation Market Absolute Opportunity, By Component, Service, 2018-2028 (USD Million)
  • Figure 42: Global Application Market CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 43: Basis Point Analysis of Global Biosimulation Market, By Application (2022, 2028)
  • Figure 44: Market Opportunity Analysis of Global Biosimulation Market, By Application (2023-2028)
  • Figure 45: Global Biosimulation Market Size, By Application, Drug Discovery, By Value, 2018-2021 (USD Million)
  • Figure 46: Global Biosimulation Market Size, By Application, Drug Discovery, By Value, 2022-2028 (USD Million)
  • Figure 47: Global Biosimulation Market Absolute Opportunity, By Application, Drug Discovery, 2018-2028 (USD Million)
  • Figure 48: Global Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2018-2021 (USD Million)
  • Figure 49: Global Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2022-2028 (USD Million)
  • Figure 50: Global Biosimulation Market Absolute Opportunity, By Application, Pre-Clinical, 2018-2028 (USD Million)
  • Figure 51: Global Biosimulation Market Size, By Application, Clinical, By Value, 2018-2021 (USD Million)
  • Figure 52: Global Biosimulation Market Size, By Application, Clinical, By Value, 2022-2028 (USD Million)
  • Figure 53: Global Biosimulation Market Absolute Opportunity, By Application, Clinical, 2018-2028 (USD Million)
  • Figure 54: Global End-User Market CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 55: Basis Point Analysis of Global Biosimulation Market, By End-User (2022,2028)
  • Figure 56: Market Opportunity Analysis of Global Biosimulation Market, By End-User (2023-2028)
  • Figure 57: Global Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2018-2021 (USD Million)
  • Figure 58: Global Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2022-2028 (USD Million)
  • Figure 59: Global Biosimulation Market Absolute Opportunity, By End-User, Academic & Government Research Institutes, 2018-2028 (USD Million)
  • Figure 60: Global Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2018-2021 (USD Million)
  • Figure 61: Global Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2022-2028 (USD Million)
  • Figure 62: Global Biosimulation Market Absolute Opportunity, By End-User, Pharmaceutical & Biotech Companies, 2018-2028 (USD Million)
  • Figure 63: Global Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2018-2021 (USD Million)
  • Figure 64: Global Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2022-2028 (USD Million)
  • Figure 65: Global Biosimulation Market Absolute Opportunity, By End-User, Contract Research Organization, 2018-2028 (USD Million)
  • Figure 66: Global Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2018-2021 (USD Million)
  • Figure 67: Global Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2022-2028 (USD Million)
  • Figure 68: Global Biosimulation Market Absolute Opportunity, By End-User, Regulatory Authorities, 2018-2028 (USD Million)
  • Figure 69: Market Value of the Americas is expected to grow from USD 1448.02 MN in 2021 to USD 4236.26 Million in 2028
  • Figure 70: Americas Biosimulation Market is expected to foresee an absolute growth rate of 16.59% during 2023-2028
  • Figure 71: Market Value by Leading Component
  • Figure 72: Market Value by Leading Application
  • Figure 73: Top 3 End-User of Biosimulation
  • Figure 74: Basis Point Analysis of Americas Biosimulation Market, By Country (2022, 2028)
  • Figure 75: Market Opportunity Analysis of Americas Biosimulation Market, By Country (2023-2028)
  • Figure 76: Americas Biosimulation Market Size, By Value, 2018-2021 (USD Million)
  • Figure 77: Americas Biosimulation Market Size, By Value, 2022-2028 (USD Million)
  • Figure 78: Americas Biosimulation Market Share, By End-User, 2021 (%)
  • Figure 79: Americas Component Market CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 80: Basis Point Analysis of Americas Biosimulation Market, By Component (2022, 2028)
  • Figure 81: Market Opportunity Analysis of Americas Biosimulation Market, By Component (2023-2028)
  • Figure 82: Americas Biosimulation Market Size, By Component, Software, By Value, 2018-2021 (USD Million)
  • Figure 83: Americas Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
  • Figure 84: Americas Component Software Footprint in Global Market, 2021 (% of Global Market)
  • Figure 85: Americas Biosimulation Market Size, By Component, Service, By Value, 2018-2021 (USD Million)
  • Figure 86: Americas Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
  • Figure 87: Americas Component Service Footprint in Global Market, 2021 (% of Global Market)
  • Figure 88: Global Biosimulation Market Size, By End-User Energy, By Value, 2022-2028 (USD Million)
  • Figure 89: Basis Point Analysis of Americas Market, By Application (2022, 2028)
  • Figure 90: Market Opportunity Analysis of Americas, By Application (2023-2028)
  • Figure 91: Americas Biosimulation Market Size, By Application, Drug Discovery, By Value, 2018-2021 (USD Million)
  • Figure 92: Americas Biosimulation Market Size, By Application, Drug Discovery, By Value, 2022-2028 (USD Million)
  • Figure 93: Americas Application Drug Discovery Footprint in Global Market, 2021 (% of Global Market)
  • Figure 94: Americas Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2018-2021 (USD Million)
  • Figure 95: Americas Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2022-2028 (USD Million)
  • Figure 96: Americas Application Pre-Clinical Footprint in Global Market, 2021 (% of Global Market)
  • Figure 97: Americas Biosimulation Market Size, By Application, Clinical, By Value, 2018-2021 (USD Million)
  • Figure 98: Americas Biosimulation Market Size, By Application, Clinical, By Value, 2022-2028 (USD Million)
  • Figure 99: Americas Application Clinical Footprint in Global Market, 2021 (% of Global Market)
  • Figure 100: Americas End-User Market CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 101: Basis Point Analysis of Americas Biosimulation Market, By End-User (2022, 2028)
  • Figure 102: Market Opportunity Analysis of Americas Biosimulation Market, By End-User (2023-2028)
  • Figure 103: Americas Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2018-2021 (USD Million)
  • Figure 104: Americas Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2022-2028 (USD Million)
  • Figure 105: Americas End-User Academic & Government Research Institutes Footprint in Global Market, 2021 (% of Global Market)
  • Figure 106: Americas Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2018-2021 (USD Million)
  • Figure 107: Americas Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, By Value, 2022-2028 (USD Million)
  • Figure 108: Americas End-User Pharmaceutical & Biotech Companies Footprint in Global Market, 2021 (% of Global Market)
  • Figure 109: Americas Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2018-2021 (USD Million)
  • Figure 110: Americas Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2022-2028 (USD Million)
  • Figure 111: Americas End-User Contract Research Organization Footprint in Global Market, 2021 (% of Global Market)
  • Figure 112: Americas Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2018-2021 (USD Million)
  • Figure 113: Americas Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2022-2028 (USD Million)
  • Figure 114: Americas End-User Regulatory Authorities Footprint in Global Market, 2021 (% of Global Market)
  • Figure 115: United States Biosimulation Market, By Value, 2018-2028 (USD Million)
  • Figure 116: United States Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 117: United States Biosimulation Market Value, By Component, 2021 (USD Million)
  • Figure 118: United States Biosimulation Market Share, By Component, By Value, 2021 (%)
  • Figure 119: United States Biosimulation Market Share, By Application, By Value, 2021 (%)
  • Figure 120: United States Biosimulation Market Share, By End-User, By Value, 2021 (%)
  • Figure 121: Canada Biosimulation Market, By Value, 2018-2028 (USD Million)
  • Figure 122: Canada Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 123: Canada Biosimulation Market Value, By Component, 2021 (USD Million)
  • Figure 124: Canada Biosimulation Market Share, By Component, By Value, 2021 (%)
  • Figure 125: Canada Biosimulation Market Share, By Application, By Value, 2021 (%)
  • Figure 126: Canada Biosimulation Market Share, By End-User, By Value, 2021 (%)
  • Figure 127: Mexico Biosimulation Market, By Value, 2018-2028 (USD Million)
  • Figure 128: Mexico Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 129: Mexico Biosimulation Market Value, By Component, 2021 (USD Million)
  • Figure 130: Mexico Biosimulation Market Share, By Component, By Value, 2021 (%)
  • Figure 131: Mexico Biosimulation Market Share, By Application, By Value, 2021 (%)
  • Figure 132: Mexico Biosimulation Market Share, By End-User, By Value, 2021 (%)
  • Figure 133: Rest of Americas Biosimulation Market, By Value, 2018-2028 (USD Million)
  • Figure 134: Rest of Americas Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 135: Rest of Americas Biosimulation Market Value, By Component, 2021 (USD Million)
  • Figure 136: Rest of Americas Biosimulation Market Share, By Component, By Value, 2021 (%)
  • Figure 137: Rest of Americas Biosimulation Market Share, By Application, By Value, 2021 (%)
  • Figure 138: Rest of Americas Biosimulation Market Share, By End-User, By Value, 2021 (%)
  • Figure 139: Market Value of the Europe is expected to grow from USD 801.96 MN in 2021 to USD 2217.55 MN in 2028
  • Figure 140: Europe Biosimulation Market is expected to foresee an absolute growth of 15.65 % during 2023-2028
  • Figure 141: Market Value by Leading Component
  • Figure 142: Market Value by Leading Application
  • Figure 143: Top 3 End-User of Biosimulation
  • Figure 144: Basis Point Analysis of Europe Biosimulation Market, By Country (2022, 2028)
  • Figure 145: Market Opportunity Analysis of Europe Biosimulation Market, By Country (2023-2028)
  • Figure 146: Europe Biosimulation Market Size, By Value, 2018-2021 (USD Million)
  • Figure 147: Europe Biosimulation Market Size, By Value, 2022-2028 (USD Million)
  • Figure 148: Europe Biosimulation Market Share, By End-User, 2021 (%)
  • Figure 149: Europe Component Market CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 150: Basis Point Analysis of Europe Biosimulation Market, By Component (2022, 2028)
  • Figure 151: Market Opportunity Analysis of Europe Biosimulation Market, By Component (2023-2028)
  • Figure 152: Europe Biosimulation Market Size, By Component, Software, By Value, 2018-2021 (USD Million)
  • Figure 153: Europe Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
  • Figure 154: Europe Component Software Footprint in Global Market, 2021 (% of Global Market)
  • Figure 155: Europe Biosimulation Market Size, By Component, Service, By Value, 2018-2021 (USD Million)
  • Figure 156: Europe Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
  • Figure 157: Europe Component Service Footprint in Global Market, 2021 (% of Global Market)
  • Figure 158: Europe Application Market CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 159: Basis Point Analysis of Europe Market, By Application (2022, 2028)
  • Figure 160: Market Opportunity Analysis of Europe, By Application (2023-2028)
  • Figure 161: Europe Biosimulation Market Size, By Application, Drug Discovery, By Value, 2018-2021 (USD Million)
  • Figure 162: Europe Biosimulation Market Size, By Application, Drug Discovery, By Value, 2022-2028 (USD Million)
  • Figure 163: Europe Application Drug Discovery Footprint in Global Market, 2021 (% of Global Market)
  • Figure 164: Europe Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2018-2021 (USD Million)
  • Figure 165: Europe Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2022-2028 (USD Million)
  • Figure 166: Europe Application Pre-Clinical Footprint in Global Market, 2021 (% of Global Market)
  • Figure 167: Europe Biosimulation Market Size, By Application, Clinical, By Value, 2018-2021 (USD Million)
  • Figure 168: Europe Biosimulation Market Size, By Application, Clinical, By Value, 2022-2028 (USD Million)
  • Figure 169: Europe Application Clinical Footprint in Global Market, 2021 (% of Global Market)
  • Figure 170: Europe End-User Market CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 171: Basis Point Analysis of Europe Biosimulation Market, By End-User (2022, 2028)
  • Figure 172: Market Opportunity Analysis of Europe Biosimulation Market, By End-User (2023-2028)
  • Figure 173: Europe Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2018-2021 (USD Million)
  • Figure 174: Europe Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2022-2028 (USD Million)
  • Figure 175: Europe End-User Academic & Government Research Institutes Footprint in Global Market, 2021 (% of Global Market)
  • Figure 176: Europe Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2018-2021 (USD Million)
  • Figure 177: Europe Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, By Value, 2022-2028 (USD Million)
  • Figure 178: Europe End-User Pharmaceutical & Biotech Companies Footprint in Global Market, 2021 (% of Global Market)
  • Figure 179: Europe Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2018-2021 (USD Million)
  • Figure 180: Europe Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2022-2028 (USD Million)
  • Figure 181: Europe End-User Contract Research Organization Footprint in Global Market, 2021 (% of Global Market)
  • Figure 182: Europe Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2018-2021 (USD Million)
  • Figure 183: Europe Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2022-2028 (USD Million)
  • Figure 184: Europe End-User Regulatory Authorities Footprint in Global Market, 2021 (% of Global Market)
  • Figure 185: Germany Biosimulation Market, By Value, 2018-2028 (USD Million)
  • Figure 186: Germany Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 187: Germany Biosimulation Market Value, By Component, 2021 (USD Million)
  • Figure 188: Germany Biosimulation Market Share, By Component, By Value, 2021 (%)
  • Figure 189: Germany Biosimulation Market Share, By Application, By Value, 2021 (%)
  • Figure 190: Germany Biosimulation Market Share, By End-User, By Value, 2021 (%)
  • Figure 191: United Kingdom Biosimulation Market, By Value, 2018-2028 (USD Million)
  • Figure 192: United Kingdom Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 193: United Kingdom Biosimulation Market Value, By Component, 2021 (USD Million)
  • Figure 194: United Kingdom Biosimulation Market Share, By Component, By Value, 2021 (%)
  • Figure 195: United Kingdom Biosimulation Market Share, By Application, By Value, 2021 (%)
  • Figure 196: United Kingdom Biosimulation Market Share, By End-User, By Value, 2021 (%)
  • Figure 197: France Biosimulation Market, By Value, 2018-2028 (USD Million)
  • Figure 198: France Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 199: France Biosimulation Market Value, By Component, 2021 (USD Million)
  • Figure 200: France Biosimulation Market Share, By Component, By Value, 2021 (%)
  • Figure 201: France Biosimulation Market Share, By Application, By Value, 2021 (%)
  • Figure 202: France Biosimulation Market Share, By End-User, By Value, 2021 (%)
  • Figure 203: Italy Biosimulation Market, By Value, 2018-2028 (USD Million)
  • Figure 204: Italy Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 205: Italy Biosimulation Market Value, By Component, 2021 (USD Million)
  • Figure 206: Italy Biosimulation Market Share, By Component, By Value, 2021 (%)
  • Figure 207: Italy Biosimulation Market Share, By Application, By Value, 2021 (%)
  • Figure 208: Italy Biosimulation Market Share, By End-User, By Value, 2021 (%)
  • Figure 209: Rest of Europe Biosimulation Market, By Value, 2018-2028 (USD Million)
  • Figure 210: Rest of Europe Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 211: Rest of Europe Biosimulation Market Value, By Component Type, 2021 (USD Million)
  • Figure 212: Rest of Europe Biosimulation Market Share, By Component, By Value, 2021 (%)
  • Figure 213: Rest of Europe Biosimulation Market Share, By Application, By Value, 2021 (%)
  • Figure 214: Rest of Europe Biosimulation Market Share, By End-User, By Value, 2021 (%)
  • Figure 215: Market Value of the Asia Pacific is expected to grow from USD 536.86 MN in 2021 to USD 1685.86 MN in 2028
  • Figure 216: Asia Pacific Biosimulation Market is expected to foresee an absolute growth of 17.76% during 2023-2028
  • Figure 217: Market Value by Leading Component
  • Figure 218: Market Value by Leading Application
  • Figure 219: Top 3 End-User of Biosimulation
  • Figure 220: Basis Point Analysis of Asia Pacific Biosimulation Market, By Country (2022, 2028)
  • Figure 221: Market Opportunity Analysis of Asia Pacific Biosimulation Market, By Country (2023-2028)
  • Figure 222: Asia Pacific Biosimulation Market Size, By Value, 2018-2021 (USD Million)
  • Figure 223: Asia Pacific Biosimulation Market Size, By Value, 2022-2028 (USD Million)
  • Figure 224: Asia Pacific Biosimulation Market Share, By End-User, 2021 (%)
  • Figure 225: Asia Pacific Component Market CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 226: Basis Point Analysis of Asia Pacific Biosimulation Market, By Component (2022, 2028)
  • Figure 227: Market Opportunity Analysis of Asia Pacific Biosimulation Market, By Component (2023-2028)
  • Figure 228: Asia Pacific Biosimulation Market Size, By Component, Software, By Value, 2018-2021 (USD Million)
  • Figure 229: Asia Pacific Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
  • Figure 230: Asia Pacific Component Software Footprint in Global Market, 2021 (% of Global Market)
  • Figure 231: Asia Pacific Biosimulation Market Size, By Component, Service, By Value, 2018-2021 (USD Million)
  • Figure 232: Asia Pacific Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
  • Figure 233: Asia Pacific Component Service Footprint in Global Market, 2021 (% of Global Market)
  • Figure 234: Asia Pacific Application Market CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 235: Basis Point Analysis of Asia Pacific Market, By Application (2022, 2028)
  • Figure 236: Market Opportunity Analysis of Asia Pacific, By Application (2023-2028)
  • Figure 237: Asia Pacific Biosimulation Market Size, By Application, Drug Discovery, By Value, 2018-2021 (USD Million)
  • Figure 238: Asia Pacific Biosimulation Market Size, By Application, Drug Discovery, By Value, 2022-2028 (USD Million)
  • Figure 239: Asia Pacific Application Drug Discovery Footprint in Global Market, 2021 (% of Global Market)
  • Figure 240: Asia Pacific Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2018-2021 (USD Million)
  • Figure 241: Asia Pacific Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2022-2028 (USD Million)
  • Figure 242: Asia Pacific Application Pre-Clinical Footprint in Global Market, 2021 (% of Global Market)
  • Figure 243: Asia Pacific Biosimulation Market Size, By Application, Clinical, By Value, 2018-2021 (USD Million)
  • Figure 244: Asia Pacific Biosimulation Market Size, By Application, Clinical, By Value, 2022-2028 (USD Million)
  • Figure 245: Asia Pacific Application Clinical Footprint in Global Market, 2021 (% of Global Market)
  • Figure 246: Asia Pacific End-User Market CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 247: Basis Point Analysis of Asia Pacific Biosimulation Market, By End-User (2022, 2028)
  • Figure 248: Market Opportunity Analysis of Asia Pacific Biosimulation Market, By End-User (2023-2028)
  • Figure 249: Asia Pacific Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2018-2021 (USD Million)
  • Figure 250: Asia Pacific Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2022-2028 (USD Million)
  • Figure 251: Asia Pacific End-User Academic & Government Research Institutes Footprint in Global Market, 2021 (% of Global Market)
  • Figure 252: Asia Pacific Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2018-2021 (USD Million)
  • Figure 253: Asia Pacific Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, By Value, 2022-2028 (USD Million)
  • Figure 254: Asia Pacific End-User Pharmaceutical & Biotech Companies Footprint in Global Market, 2021 (% of Global Market)
  • Figure 255: Asia Pacific Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2018-2021 (USD Million)
  • Figure 256: Asia Pacific Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2022-2028 (USD Million)
  • Figure 257: Asia Pacific End-User Contract Research Organization Footprint in Global Market, 2021 (% of Global Market)
  • Figure 258: Asia Pacific Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2018-2021 (USD Million)
  • Figure 259: Asia Pacific Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2022-2028 (USD Million)
  • Figure 260: Asia Pacific End-User Regulatory Authorities Footprint in Global Market, 2021 (% of Global Market)
  • Figure 261: China Biosimulation Market, By Value, 2018-2028 (USD Million)
  • Figure 262: China Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 263: China Biosimulation Market Value, By Component, 2021 (USD Million)
  • Figure 264: China Biosimulation Market Share, By Component, By Value, 2021 (%)
  • Figure 265: China Biosimulation Market Share, By Application, By Value, 2021 (%)
  • Figure 266: China Biosimulation Market Share, By End-User, By Value, 2021 (%)
  • Figure 267: Japan Biosimulation Market, By Value, 2018-2028 (USD Million)
  • Figure 268: Japan Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 269: Japan Biosimulation Market Value, By Component Type, 2021 (USD Million)
  • Figure 270: Japan Biosimulation Market Share, By Component, By Value, 2021 (%)
  • Figure 271: Japan Biosimulation Market Share, By Application, By Value, 2021 (%)
  • Figure 272: Japan Biosimulation Market Share, By End-User, By Value, 2021 (%)
  • Figure 273: India Biosimulation Market, By Value, 2018-2028 (USD Million)
  • Figure 274: India Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 275: India Biosimulation Market Value, By Component Type, 2021 (USD Million)
  • Figure 276: India Biosimulation Market Share, By Component, By Value, 2021 (%)
  • Figure 277: India Biosimulation Market Share, By Application, By Value, 2021 (%)
  • Figure 278: India Biosimulation Market Share, By End-User, By Value, 2021 (%)
  • Figure 279: Rest of APAC Biosimulation Market, By Value, 2018-2028 (USD Million)
  • Figure 280: Rest of APAC Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 281: Rest of APAC Biosimulation Market Value, By Component Type, 2021 (USD Million)
  • Figure 282: Rest of APAC Biosimulation Market Share, By Component, By Value, 2021 (%)
  • Figure 283: Rest of APAC Biosimulation Market Share, By Application, By Value, 2021 (%)
  • Figure 284: Rest of APAC Biosimulation Market Share, By End-User, By Value, 2021 (%)
  • Figure 285: Market Value of the Middle East & Africa is expected to grow from USD 224.66 MN in 2021 to USD 505.76 MN in 2028
  • Figure 286: Middle East & Africa Biosimulation Market is expected to foresee an absolute growth of 12.18% during 2023-2028
  • Figure 287: Market Value by Leading Component
  • Figure 288: Market Value by Leading Application
  • Figure 289: Top 3 End-User of Biosimulation
  • Figure 290: Middle East & Africa Biosimulation Market Size, By Value, 2018-2021 (USD Million)
  • Figure 291: Middle East & Africa Biosimulation Market Size, By Value, 2022-2028 (USD Million)
  • Figure 292: Middle East & Africa Biosimulation Market Share, By End-User, 2021 (%)
  • Figure 293: Middle East & Africa Component Market CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 294: Basis Point Analysis of Middle East & Africa Biosimulation Market, By Component (2022,2028)
  • Figure 295: Market Opportunity Analysis of Middle East & Africa Biosimulation Market, By Component (2023-2028)
  • Figure 296: Middle East & Africa Biosimulation Market Size, By Component, Software, By Value, 2018-2021 (USD Million)
  • Figure 297: Middle East & Africa Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
  • Figure 298: Middle East & Africa Component Software Footprint in Global Market, 2021 (% of Global Market)
  • Figure 299: Middle East & Africa Biosimulation Market Size, By Component, Service, By Value, 2018-2021 (USD Million)
  • Figure 300: Middle East & Africa Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
  • Figure 301: Middle East & Africa Component Service Footprint in Global Market, 2021 (% of Global Market)
  • Figure 302: Middle East & Africa Application Market CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 303: Basis Point Analysis of Middle East & Africa Market, By Application (2022,2028)
  • Figure 304: Market Opportunity Analysis of Middle East & Africa, By Application (2023-2028)
  • Figure 305: Middle East & Africa Biosimulation Market Size, By Application, Drug Discovery, By Value, 2018-2021 (USD Million)
  • Figure 306: Middle East & Africa Biosimulation Market Size, By Application, Drug Discovery, By Value, 2022-2028 (USD Million)
  • Figure 307: Middle East & Africa Application Drug Discovery Footprint in Global Market, 2021 (% of Global Market)
  • Figure 308: Middle East & Africa Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2018-2021 (USD Million)
  • Figure 309: Middle East & Africa Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2022-2028 (USD Million)
  • Figure 310: Middle East & Africa Application Pre-Clinical Footprint in Global Market, 2021 (% of Global Market)
  • Figure 311: Middle East & Africa Biosimulation Market Size, By Application, Clinical, By Value, 2018-2021 (USD Million)
  • Figure 312: Middle East & Africa Biosimulation Market Size, By Application, Clinical, By Value, 2022-2028 (USD Million)
  • Figure 313: Middle East & Africa Application Clinical Footprint in Global Market, 2021 (% of Global Market)
  • Figure 314: Middle East & Africa End-User Market CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 315: Basis Point Analysis of Middle East & Africa Biosimulation Market, By End-User (2022, 2028)
  • Figure 316: Market Opportunity Analysis of Middle East & Africa Biosimulation Market, By End-User (2023-2028)
  • Figure 317: Middle East & Africa Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2018-2021 (USD Million)
  • Figure 318: Middle East & Africa Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2022-2028 (USD Million)
  • Figure 319: Middle East & Africa End-User Academic & Government Research Institutes Footprint in Global Market, 2021 (% of Global Market)
  • Figure 320: Middle East & Africa Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2018-2021 (USD Million)
  • Figure 321: Middle East & Africa Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, By Value, 2022-2028 (USD Million)
  • Figure 322: Middle East & Africa End-User Pharmaceutical & Biotech Companies Footprint in Global Market, 2021 (% of Global Market)
  • Figure 323: Middle East & Africa Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2018-2021 (USD Million)
  • Figure 324: Middle East & Africa Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2022-2028 (USD Million)
  • Figure 325: Middle East & Africa End-User Contract Research Organization Footprint in Global Market, 2021 (% of Global Market)
  • Figure 326: Middle East & Africa Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2018-2021 (USD Million)
  • Figure 327: Middle East & Africa Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2022-2028 (USD Million)
  • Figure 328: Middle East & Africa End-User Regulatory Authorities Footprint in Global Market, 2021 (% of Global Market)

List of Tables

Table 1: Global Impact of Drivers and Restraints

Table 2: Key Company Financials, 2019-2021

Table 3: Key Company Financials, 2019-2021

Table 4: Key Company Financials, 2019-2021

Table 5: Key Company Financials, 2019-2021

Table 6: Key Company Financials, 2019-2021

Table 7: Key Company Financials, 2019-2021

Table 8: Key Company Financials, 2019-2021

Table 9: Global Impact of Macro Economic Factors, By Region

Table 10: Americas Impact of Macro Economic Factors, By Country

Table 11: Americas Impact of Drivers and Restraints

Table 12: United States Biosimulation Market, By Component, By Value, 2018-2021 (USD Million)

Table 13: United States Biosimulation Market, By Component, By Value, 2022-2028 (USD Mi